16/02/2021 | News & Events / News

Healthware Group and Plexus Ventures Form Alliance to Accelerate Partnerships Between Digital Therapeutics & Pharma

 
 
 
Share
 

Milan and New York, 16/2/2021 – Healthware Group and Plexus Ventures have formed an alliance to structure deals for the pharmaceutical industry in the development and commercialization of DTx products. Given the increased attention and growth seen in the market, both companies are leveraging their expertise to become go-to partners for life sciences companies looking to incorporate DTx into their pipelines.

Plexus Ventures brings to the alliance over thirty years of experience and strategic knowledge of the pharma industry, long-established industry relationships, partnering experience and a time tested process to development and commercialization deals.

Healthware brings several decades of software app development and expertise as well as a history of digitally focused relationships with pharma. Healthware has also developed an investment fund to support and invest in digital health companies and nurtures a vast digital health network and expertise. In the area of digital therapeutics, Healthware Group supports both the research & development of DTx products as well as the go to market strategy of those products. This can be in partnership with pharma or supporting DTx companies in their growth.

One of the goals of the alliance is to educate pharma companies as to the value of digital therapeutics for their business model.

"Healthware was created over 20 years ago based upon a recognition of the anticipated convergence of healthcare + software", says CEO & Founder, Roberto Ascione. "With the growth of digital therapeutics, that convergence has grown even stronger and it’s clear that strategic partnerships across the industry will continue to play a vital role in advancing the field of digital health and digital therapeutics. We’re excited to partner with Plexus Ventures to help bring this knowledge to pharma and leverage their expertise and relationships in structuring potential deals, co-development and go to market programs".

 

With regards to the alliance, Bob Moran, President at Plexus Ventures states,

"We have been structuring deals for pharma companies for over 30 years, focused on molecules and consumer products. It has become clear to us that pharma companies are scouting the new digital therapeutics space, seeking deals to combine digital products and applications with their business models. We are thrilled to partner with Healthware, a leader in the digital health ecosystem, to forge successful pharma-digital therapeutics alliances."